Dialysis does increase stroke risk. People on long-term dialysis experience ischemic strokes (caused by blood clots) at roughly 2.5 times the rate of the general population, and hemorrhagic strokes (caused by bleeding) at nearly 5 to 6 times the rate. The dialysis procedure itself plays a direct role, but so do the underlying conditions that led to kidney failure in the first place. Understanding which factors you can influence makes a real difference.
How Much Higher Is the Risk?
A large cohort study comparing dialysis patients to an age- and sex-matched general population found ischemic stroke rates of about 103 per 10,000 person-years in hemodialysis patients, compared to 42 per 10,000 in the reference group. For hemorrhagic stroke, the gap was even wider: roughly 75 per 10,000 person-years in hemodialysis patients versus just 13 per 10,000 in the general population. Over a median follow-up period, about 5% of dialysis patients experienced an ischemic stroke and around 2 to 3% had a hemorrhagic stroke.
Peritoneal dialysis, the home-based alternative, carries a similar ischemic stroke risk but appears to have a modestly lower risk of hemorrhagic stroke compared to hemodialysis, with a roughly 25% reduction after adjusting for other health factors.
Why Dialysis Itself Raises Stroke Risk
The hemodialysis procedure removes fluid and waste from the blood over a few hours, creating rapid shifts in blood pressure, electrolytes, and fluid volume. These swings are the core problem. About one in four hemodialysis sessions produces a measurable drop in oxygen reaching the brain, defined as a 15% decline from baseline cerebral oxygen levels. That drop is directly tied to falling blood pressure during the session.
Intradialytic hypotension, the sharp blood pressure drop that many patients experience mid-session, is the most well-studied trigger. When pressure falls too quickly, blood flow to the brain can temporarily become insufficient. Over years of treatment, the cumulative effect of repeated low-pressure episodes is associated with long-term brain damage, including a higher five-year risk of new-onset dementia. Beyond volume shifts, rapid changes in sodium and other electrolytes, along with inflammatory responses triggered by the dialysis circuit, also stress the vascular system.
A Japanese study of 151 hemodialysis patients with acute stroke found that about 40% of brain infarcts and 35% of brain hemorrhages happened during or within 30 minutes after a dialysis session. However, data from another cohort showed a more distributed pattern: of 90 strokes in hemodialysis patients, 10 occurred during dialysis, 17 later that same day, and 35 on a non-dialysis day. So while the procedure itself is a trigger, strokes can and do happen at any time.
The First Weeks on Dialysis Are the Riskiest
Stroke risk is not constant over the course of treatment. It begins climbing about 90 days before dialysis starts, likely reflecting how sick the kidneys already are at that point. The risk then peaks sharply during the first 30 days after dialysis initiation, reaching roughly 8.4% per patient-year for those who start as outpatients and 18% per patient-year for those who begin during a hospital stay. By one to two months after starting, the rate drops considerably and eventually stabilizes at about twice whatever the patient’s baseline rate was before kidney failure progressed.
This early spike likely reflects the combined stress of severely impaired kidney function, the body’s adjustment to a new treatment, and the hemodynamic instability that comes with the first several sessions before fluid targets and treatment parameters are fine-tuned.
Underlying Conditions That Compound the Risk
Dialysis patients carry a heavy burden of conditions that independently raise stroke risk, making it difficult to separate the contribution of dialysis from everything else going on.
Atrial fibrillation is a major factor. About 7% of dialysis patients have chronic atrial fibrillation at any given time, a rate roughly ten times higher than in the general population. Over time, about 10% of dialysis patients develop it. Chronic atrial fibrillation independently raises the risk of ischemic stroke in this group by about 26%. During periods of active atrial fibrillation, the overall stroke rate rises from 22.2 to 28.2 per 1,000 patient-years.
Vascular calcification is another major contributor. Chronic kidney disease accelerates the buildup of calcium in artery walls through a metabolic process distinct from typical atherosclerosis. This calcification stiffens blood vessels, impairs the brain’s blood flow regulation, and is linked to both large vessel stroke and small vessel disease in the brain. Diabetes, which is common in dialysis patients, worsens this calcification further.
Does Blood Thinner Use During Dialysis Add Risk?
Hemodialysis circuits require an anticoagulant to prevent clotting in the tubing and filter, and heparin is the standard choice. Given that dialysis patients already face a hemorrhagic stroke risk five times higher than the general population, it’s reasonable to wonder whether heparin contributes. The available evidence suggests it does not meaningfully add to this risk.
In one study of Japanese hemodialysis patients, 85% of brain hemorrhages occurred more than six hours after the session ended. Since heparin’s effects wear off within about an hour, the timing makes heparin an unlikely cause. A separate study in the same population found that hemorrhages occurred on average 35.5 hours after the last session. And when researchers compared heparin doses between patients who had hemorrhagic strokes and those who didn’t, there was no difference.
How Stroke Outcomes Differ for Dialysis Patients
When dialysis patients do have strokes, the outcomes are significantly worse than for the general population. Thirty-day mortality after an ischemic stroke is about 18 to 20%, compared to roughly 10 to 12% in the broader population. For hemorrhagic stroke, the numbers are far grimmer: 30-day mortality exceeds 53%. That means more than half of dialysis patients who experience a brain bleed do not survive the first month.
These stark numbers reflect the fragile overall health of most dialysis patients, the difficulty of using standard stroke treatments in people with kidney failure, and the complications that arise when dialysis must continue during stroke recovery.
Recognizing Stroke Symptoms During Treatment
Because a meaningful percentage of strokes happen during or shortly after dialysis, knowing the warning signs matters for both patients and caregivers. The classic signs apply: sudden facial drooping, arm weakness, speech difficulty, sudden severe headache, or vision changes. The challenge during dialysis is that some symptoms overlap with common treatment side effects. Nausea, headache, and disorientation can signal a condition called dialysis disequilibrium syndrome, which involves swelling and pressure changes in the brain and can mimic or mask stroke symptoms.
Any sudden neurological change during a session, particularly one-sided weakness, slurred speech, or confusion that doesn’t resolve quickly, should be treated as a potential stroke. Speed matters enormously in stroke treatment, and the window for effective intervention is measured in hours.
Reducing Your Risk
Blood pressure management is the single most important lever. Working with your care team to minimize extreme blood pressure swings during sessions, through adjustments to fluid removal rates, dialysate composition, and session length, can reduce the repeated low-flow episodes that damage the brain over time. Slower, longer, or more frequent dialysis sessions generally produce gentler hemodynamic shifts.
Managing atrial fibrillation is critical but complicated, since the standard blood thinners used to prevent stroke in AF carry additional bleeding risks in dialysis patients. Controlling other cardiovascular risk factors, including blood sugar, cholesterol, and phosphorus levels (which drive vascular calcification), also helps. Peritoneal dialysis may be worth discussing with your nephrologist if hemorrhagic stroke risk is a particular concern, given the modestly lower rate observed in studies.